← Back to Search
Behavioral Intervention
Telehealth Screening Solutions for Colorectal Cancer (PRIME Trial)
Los Angeles, CA
N/A
Recruiting
Led By Anne Escaron, PhD
Research Sponsored by University of Arizona
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages 45-64
Primary speaker of English or Spanish
Must not have
Colorectal disease (e.g., ulcerative colitis or colectomy)
Personal history of colorectal cancer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new way to screen for colorectal cancer using a multi-level approach. It is not random, and participants will be split into two groups to compare the effectiveness of the new screening
Who is the study for?
This trial is for individuals aged 45-64 who are due for colorectal cancer screening, have visited the clinic in the past 6 months, speak English or Spanish, live in certain neighborhoods part of the study, and have a cell phone listed in their health records. Those with recent CRC screenings can't join.
What is being tested?
The trial tests a multi-level intervention to increase colorectal cancer screening rates. It includes promoting screenings at clinics, mailing fecal immunochemical test (FIT) kits to people's homes, sending reminders and video text messages about screening importance, and helping with social needs that may affect health care access.
What are the potential side effects?
Since this trial focuses on increasing cancer screening through communication methods rather than medication or medical procedures, there are no direct side effects from interventions like you might expect with drug trials.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 45 and 64 years old.
Select...
I primarily speak English or Spanish.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a history of colorectal disease such as ulcerative colitis or have had a colectomy.
Select...
I have had colorectal cancer in the past.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
CRC Screening Completion at the Individual Level
Secondary study objectives
FIT completion
Rate of Follow-Up Colonoscopy Completion
Time to follow-up colonoscopy
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Video text message, mailed FIT, and social needs navigationExperimental Treatment3 Interventions
Tailored video text message, mailed FIT, and navigation to address patients' social needs.
Group II: Usual careActive Control2 Interventions
Colorectal cancer (CRC) screening offers during in-person clinic visits.
Find a Location
Closest Location:AltaMed Health Services Corporation· Los Angeles, CA
Who is running the clinical trial?
Kaiser PermanenteOTHER
561 Previous Clinical Trials
27,393,320 Total Patients Enrolled
University of ArizonaLead Sponsor
544 Previous Clinical Trials
154,556 Total Patients Enrolled
AltaMed Health Services CorporationOTHER
10 Previous Clinical Trials
31,674 Total Patients Enrolled
San Diego State UniversityOTHER
179 Previous Clinical Trials
112,422 Total Patients Enrolled
Anne Escaron, PhDPrincipal InvestigatorAltaMed Health Services Corporation